These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 34177942)
1. The Role of CLEC-2 and Its Ligands in Thromboinflammation. Meng D; Luo M; Liu B Front Immunol; 2021; 12():688643. PubMed ID: 34177942 [TBL] [Abstract][Full Text] [Related]
2. Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood. Suzuki-Inoue K; Osada M; Ozaki Y J Thromb Haemost; 2017 Feb; 15(2):219-229. PubMed ID: 27960039 [TBL] [Abstract][Full Text] [Related]
4. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin. Suzuki-Inoue K Blood; 2019 Nov; 134(22):1912-1918. PubMed ID: 31778548 [TBL] [Abstract][Full Text] [Related]
5. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin. Suzuki-Inoue K Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):175-181. PubMed ID: 31808911 [TBL] [Abstract][Full Text] [Related]
6. Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet Agonist. Morán LA; Di Y; Sowa MA; Hermida-Nogueira L; Barrachina MN; Martin E; Clark JC; Mize TH; Eble JA; Moreira D; Pollitt AY; Loza MI; Domínguez E; Watson SP; García Á Thromb Haemost; 2022 Aug; 122(8):1361-1368. PubMed ID: 35170009 [TBL] [Abstract][Full Text] [Related]
7. Thrombomodulation via CLEC-2 targeting. O'Callaghan CA Curr Opin Pharmacol; 2009 Apr; 9(2):90-5. PubMed ID: 19091630 [TBL] [Abstract][Full Text] [Related]
8. Functional characterization of recombinant snake venom rhodocytin: rhodocytin mutant blocks CLEC-2/podoplanin-dependent platelet aggregation and lung metastasis. Sasaki T; Shirai T; Tsukiji N; Otake S; Tamura S; Ichikawa J; Osada M; Satoh K; Ozaki Y; Suzuki-Inoue K J Thromb Haemost; 2018 May; 16(5):960-972. PubMed ID: 29488681 [TBL] [Abstract][Full Text] [Related]
9. The physiological and pathophysiological roles of platelet CLEC-2. Navarro-Núñez L; Langan SA; Nash GB; Watson SP Thromb Haemost; 2013 Jun; 109(6):991-8. PubMed ID: 23572154 [TBL] [Abstract][Full Text] [Related]
10. Vascular Smooth Muscle Cells Stimulate Platelets and Facilitate Thrombus Formation through Platelet CLEC-2: Implications in Atherothrombosis. Inoue O; Hokamura K; Shirai T; Osada M; Tsukiji N; Hatakeyama K; Umemura K; Asada Y; Suzuki-Inoue K; Ozaki Y PLoS One; 2015; 10(9):e0139357. PubMed ID: 26418160 [TBL] [Abstract][Full Text] [Related]
12. CLEC-2 Prevents Accumulation and Retention of Inflammatory Macrophages During Murine Peritonitis. Bourne JH; Beristain-Covarrubias N; Zuidscherwoude M; Campos J; Di Y; Garlick E; Colicchia M; Terry LV; Thomas SG; Brill A; Bayry J; Watson SP; Rayes J Front Immunol; 2021; 12():693974. PubMed ID: 34163489 [TBL] [Abstract][Full Text] [Related]
13. [A role of the platelet receptor CLEC-2 in lymphangiogenesis and its clinical application]. Osada M; Suzuki-Inoue K; Inoue O; Ozaki Y Rinsho Byori; 2013 Apr; 61(4):318-27. PubMed ID: 23855188 [TBL] [Abstract][Full Text] [Related]
14. The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary metastasis. Sheng M; Sun R; Fu J; Lu G BMC Cancer; 2024 Apr; 24(1):399. PubMed ID: 38561690 [TBL] [Abstract][Full Text] [Related]
15. Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells. Osada M; Inoue O; Ding G; Shirai T; Ichise H; Hirayama K; Takano K; Yatomi Y; Hirashima M; Fujii H; Suzuki-Inoue K; Ozaki Y J Biol Chem; 2012 Jun; 287(26):22241-52. PubMed ID: 22556408 [TBL] [Abstract][Full Text] [Related]
16. Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2. Acton SE; Astarita JL; Malhotra D; Lukacs-Kornek V; Franz B; Hess PR; Jakus Z; Kuligowski M; Fletcher AL; Elpek KG; Bellemare-Pelletier A; Sceats L; Reynoso ED; Gonzalez SF; Graham DB; Chang J; Peters A; Woodruff M; Kim YA; Swat W; Morita T; Kuchroo V; Carroll MC; Kahn ML; Wucherpfennig KW; Turley SJ Immunity; 2012 Aug; 37(2):276-89. PubMed ID: 22884313 [TBL] [Abstract][Full Text] [Related]
17. Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation. Suzuki-Inoue K J Biochem; 2011 Aug; 150(2):127-32. PubMed ID: 21693546 [TBL] [Abstract][Full Text] [Related]
18. Syk and Src family kinases regulate C-type lectin receptor 2 (CLEC-2)-mediated clustering of podoplanin and platelet adhesion to lymphatic endothelial cells. Pollitt AY; Poulter NS; Gitz E; Navarro-Nuñez L; Wang YJ; Hughes CE; Thomas SG; Nieswandt B; Douglas MR; Owen DM; Jackson DG; Dustin ML; Watson SP J Biol Chem; 2014 Dec; 289(52):35695-710. PubMed ID: 25368330 [TBL] [Abstract][Full Text] [Related]
19. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Bertozzi CC; Schmaier AA; Mericko P; Hess PR; Zou Z; Chen M; Chen CY; Xu B; Lu MM; Zhou D; Sebzda E; Santore MT; Merianos DJ; Stadtfeld M; Flake AW; Graf T; Skoda R; Maltzman JS; Koretzky GA; Kahn ML Blood; 2010 Jul; 116(4):661-70. PubMed ID: 20363774 [TBL] [Abstract][Full Text] [Related]